Ledger. Australian venture funding, tracked

Startup · $873.4k raised

Setonix Pharmaceuticals

Coverage

Stories naming Setonix Pharmaceuticals. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

60 deals

WA Innovators Share $8.5m In WA Government Grants

Western Australia's government has awarded $8.5 million in grants across three schemes, a health innovation seed fund, commercialisation bridge grants and innovation booster grants, naming dozens of local recipients.

Startup News (WA) 27 Jun 2024 Agili8Australian Institute of Robotic Orthopaedics Pty LtdBiotome Pty LtdCapability XCoraMetix Pty LtdCurtin UniversityCustoma Pty LtdEat SustainablyHermes and SoteriaInspiring HoldingsJuice Batteries Pty LtdMagic Wavelength Pty LtdMyTabNeolixir LtdNeurotologixREX OrthoSetonix PharmaceuticalsSpaceDraft Pty LtdSpotSynGenis Pty LtdUniversity of Western AustraliaVeinTechVetChipWhole Green FoodsY-Trace Pty LtdDASH Technology GroupWA Future Health Research and Innovation FundState GovernmentWA GovernmentStephen Dawson
8 deals

Funding Australia’s Future Economy: CUREator Deploys $7.21 Million to Propel local Life Sciences Potential

CUREator, Brandon BioCatalyst's government-backed grant program, has awarded $7.21 million across eight Australian biotech firms in its newest round, split between clinical-stage and preclinical recipients.

Brandon Capital portfolio 7 May 2024 Currus BiologicsENA RespiratoryFrontier Inflammasome TherapeuticsGPN VaccinesOncoStrike BiopharmaPolyactivaRespirion Pharmaceuticals Pty LtdSetonix PharmaceuticalsBrandon CapitalCSIROMedical Research Future FundQueensland Emory Drug Discovery InitiativeUniQuestUniversity of QueenslandBrandon BioCatalystDr Amanda VrseljaProfessor Kate SchroderKirrily DavisProfessor Tim Hirst

Also Brandon BioCatalyst portfolio·Startup Daily·ausceleratesa.org

Funding announcement

Australia’s first national biotech incubator announces round one funding to support life science breakthroughs

Brandon BioCatalyst's CUREator incubator names its first-round awardees, distributing government-backed funding across 23 Australian life science companies working on treatments from schizophrenia to diabetes, with round two applications now open.

Brandon BioCatalyst portfolio 20 Jul 2022 Alyra BiotechAxelia OncologyAzura OphthalmicsCarsinosaCassowary PharmaCurrus BiologicsDentericFLEX ImmunotherapeuticsFrontier Inflammasome TherapeuticsGeniumGeorge MedicinesLASEREDD TherapeuticsLiperate TherapeuticsMirugenMPI BiotechMyostellarNelcanen TherapeuticsOccuRxOmega-one TherapeuticsPhrenix TherapeuticsProKardiaRAGE BiotechSetonix PharmaceuticalsBrandon BioCatalystBrandon CapitalCSIROMana CommunicationsMedical Research Future FundProfessor Chris LangmeadDr Chris NaveCiara ByrneDamon BirrellProfessor Merlin ThomasDr Simon Wilkins
3 deals

Australia's first national biotech incubator announces round one funding to support life science breakthroughs

The CUREator incubator, run by Brandon BioCatalist's partner organisation, names its first-round awardees, distributing government-backed grant funding across 23 Australian life science companies developing treatments for diseases including diabetes, cancer and COPD.

Brandon Capital portfolio 20 Jul 2022 Alyra BiotechAxelia OncologyAzura OphthalmicsCarsinosaCassowary PharmaCurrus BiologicsDentericFLEX ImmunotherapeuticsFrontier Inflammasome TherapeuticsGeniumGeorge MedicinesLASEREDD TherapeuticsLiperate TherapeuticsMirugenMPI BiotechMyostellarNelcanen TherapeuticsOccuRxOmega-one TherapeuticsPhrenix TherapeuticsProKardiaRAGE BiotechSetonix PharmaceuticalsBrandon CapitalBrandon BioCatalystCSIROMedical Research Future FundProfessor Chris LangmeadDr Chris NaveProfessor Merlin ThomasDr Simon Wilkins

Something wrong? Tell us